We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Li Auto
LI
$12.6B
| $31.2M | 0.07% |
813,913
-12,509
| -2% | -$334K |
|
352
Franklin Resources
BEN
$17.1B
| $31.1M | 0.07% |
1,362,289
+293,024
| +27% | +$7.49M |
|
|
CTRA
353
DELISTED
Coterra Energy
CTRA
| $31M | 0.07% |
1,201,456
-1,151,506
| -49% | -$34.9M |
|
354
Teradyne
TER
$58B
| $30.9M | 0.07% |
349,230
+34,597
| +11% | +$3.6M |
|
|
PXD
355
DELISTED
Pioneer Natural Resource Co.
PXD
| $30.7M | 0.07% |
137,735
+30,189
| +28% | +$7.66M |
|
356
CubeSmart
CUBE
$9.2B
| $30.7M | 0.07% |
720,100
+144,525
| +25% | +$6.65M |
|
357
Cracker Barrel
CBRL
$1.26B
| $30.6M | 0.07% |
370,840
-7,398
| -2% | -$769K |
|
358
Sensata Technologies
ST
$6.73B
| $30.5M | 0.07% |
747,140
+374,667
| +101% | +$17.2M |
|
359
MetLife
MET
$61.7B
| $30.4M | 0.07% |
494,380
+66,610
| +16% | +$4.41M |
|
360
Otis Worldwide
OTIS
$27.6B
| $30.2M | 0.07% |
436,433
-211,751
| -33% | -$15.6M |
|
361
Texas Capital Bancshares
TCBI
$4.3B
| $30.2M | 0.07% |
585,003
+168,144
| +40% | +$9.02M |
|
362
Stryker
SYK
$132B
| $30.2M | 0.07% |
154,898
+1,759
| +1% | +$413K |
|
363
Ralph Lauren
RL
$24.2B
| $30.1M | 0.07% |
341,250
+112,641
| +49% | +$11.4M |
|
364
Microchip Technology
MCHP
$44.8B
| $29.9M | 0.07% |
527,736
-296
| -0.1% | -$19.6K |
|
|
SCHW
365
Charles Schwab
SCHW
$188B
| $29.9M | 0.07% |
487,658
-220,225
| -31% | -$15.2M |
|
366
Advance Auto Parts
AAP
$3.33B
| $29.6M | 0.07% |
170,742
+15,101
| +10% | +$2.99M |
|
367
Sempra
SRE
$55.1B
| $29.5M | 0.07% |
392,876
+83,828
| +27% | +$6.73M |
|
368
Essential Utilities
WTRG
$11.3B
| $29.5M | 0.07% |
647,825
-26,764
| -4% | -$1.24M |
|
369
CDW
CDW
$17.1B
| $29.3M | 0.07% |
189,046
-276,068
| -59% | -$46.4M |
|
|
TMHC
370
DELISTED
Taylor Morrison
TMHC
| $29.1M | 0.07% |
1,291,450
+877,614
| +212% | +$23.2M |
|
371
East-West Bancorp
EWBC
$18B
| $29M | 0.07% |
457,671
-3,456
| -0.7% | -$248K |
|
372
Corning
GLW
$138B
| $28.9M | 0.07% |
920,752
+299,162
| +48% | +$10.3M |
|
373
Bruker
BRKR
$8.59B
| $28.9M | 0.07% |
468,621
+73,098
| +18% | +$4.48M |
|
374
nVent Electric
NVT
$26.5B
| $28.9M | 0.07% |
941,111
-22,602
| -2% | -$771K |
|
375
Ford
F
$56B
| $28.8M | 0.07% |
2,627,116
-1,796,757
| -41% | -$24.6M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.